Trump's Generic Drug Tariffs to Hit 100% by August 2028

President Donald Trump announced that generic drugs imported into the U.S. will face a 100% tariff starting in August 2028, rising to 200% in August 2029, after an initial two-year period with zero tariffs beginning August 1, 2026. This phased tariff schedule aims to incentivize domestic production of generic drugs. The U.S. imports nearly 50% of its generics from India, which significantly relies on the U.S. market for pharmaceutical exports. Ordinary investors should monitor these changes as they may impact the profitability and operations of major drugmakers like Eli Lilly and Pfizer (PFE).